|Interim considerations for COVID-19 vaccination of healthcare personnel and long-term care facility residents||Centers for Disease Control and Prevention|
|Use of Pfizer-BioNTech COVID-19 vaccine: Clinical considerations||Moderna announces primary efficacy analysis in phase 3 COVE study for its COVID-19 vaccine candidate and filing today with the U|
FDA takes additional action in fight against COVID-19 by issuing emergency use authorization for second COVID-19 vaccine.
|Centers for Disease Control and Prevention||Centers for Disease Control and Prevention|
|Centers for Disease Control and Prevention||Benefits of getting a COVID-19 vaccine|
Centers for Disease Control and Prevention.10
|Vaccination considerations for persons with underlying medication conditions||What to expect after getting a COVID-19 vaccine|
|Janssen COVID-19 vaccine: Fact sheet for healthcare providers administering vaccine||Interim public health recommendations for vaccinated people|
Pfizer-BioNTech vaccine: Fact sheet for recipients and caregivers.